Novel radial artery occlusion device removes the guesswork from achieving Patent Hemostasis HOLLAND, Mich., Dec. 9, 2020 /PRNewswire/ — Genesis Innovation Group’s cultivate(MD) Capital Fund II LP, a fund focused on investments into early stage healthcare companies with innovative technologies, announces that one of their portfolio companies, Wheaton, IL-based Medical Ingenuities, a medical device company […]
Other News
Artio Medical Expands Leadership Team, Hires General Counsel and Vice President of Corporate Development
Prairie Village, KS – December 8, 2020 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the appointment of John Ayres to the position of Vice President of Corporate Development and General Counsel. Mr. Ayres comes to […]
Canon Medical Recognized with Best Service Awards from IMV ServiceTrak
Recognition for CT and MR Service Based on Over 1000 Customer Surveys TUSTIN, Calif.–(BUSINESS WIRE)–Canon Medical Systems USA, Inc. has earned top awards for CT and MR service according to data gathered during IMV’s 2020 ServiceTrak customer surveys. The award in each category is given to imaging system providers that receive […]
Stanford Surgeon Venita Chandra Joins Alucent Biomedical Scientific Advisory Board as Company Enters Arteriovenous Fistula Market
SALT LAKE CITY–(BUSINESS WIRE)–Alucent Biomedical, a privately held medical technology company founded to transform the way vascular disease is treated, today announced Venita Chandra, M.D., will join the company’s scientific advisory board. Dr. Chandra is board certified in both general and vascular surgery. She is a clinical associate professor of surgery […]
Neovasc Announces US$6.1 Million Registered Direct Offering Priced At-the-Market
VANCOUVER and MINNEAPOLIS, MN, Dec. 08, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc, Inc.(“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 6,230,803 common shares at a purchase price of US$0.9801 per common […]
Itamar Medical Announces Results from Multi-Center Study Validate Use of WatchPAT™ in Diagnosing Sleep Apnea in Patients with AFib
CAESAREA, Israel, Dec. 08, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company leading the integration of sleep apnea management into the cardiac patient care pathway, today announced the publication of a new study titled, ‘Watch-PAT is Useful in the Diagnosis of […]
OMRON Strengthens Engagement with AliveCor with Series E Investment, Reinforces Cross-company Alliance for Remote Cardiovascular Condition Management
KYOTO, Japan, Nov. 24, 2020 /PRNewswire/ — OMRON Healthcare Co., Ltd. announced on November 24 additional investment into AliveCor by its parent company, OMRON Corporation, as part of $65 million series E funding for the leader in AI-based personal electrocardiogram (ECG) technology. OMRON led this round of investment, reinforcing the cross-company collaboration that began in 2017. The companies continue to […]
VivaLNK Expands Medical Data Platform as it Experiences Rapid Growth in Remote Patient Monitoring Worldwide
VivaLNK’s Data Platform boasts over 90 healthcare solution partners across 22 countries as RPM adoption increases CAMPBELL, Calif., Dec. 8, 2020 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare solutions for remote patient monitoring (RPM), today announces the expansion of its Medical Data Platform for global partners. The Platform is designed for […]
Sequana Medical to Host KOL Event on “The Challenge of Diuretic Resistance in the Management of Heart Failure Patients and the Potential for alfapump® DSR therapy”
Live webcast with Dr. Jeffrey Testani on 11 December 2020 at 03:00pm CET/09:00am EST GHENT, Belgium, Dec. 07, 2020 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces that it will hold a key opinion […]
GEN inCode Appoints Chief Financial Officer
OXFORD, England, Dec. 7, 2020 /PRNewswire/ — GEN inCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease announces today the appointment of Paul Foulger as Chief Financial Officer to the Company. Paul Foulger is an experienced CFO with a proven, demonstrable track record in the Biotech industry for both […]



